PDK regulated Warburg effect protects differentiated adipocytes against ROS

dc.contributor.advisorMarch, Keith L.
dc.contributor.authorRoell, William Christopher
dc.contributor.otherConsidine, Robert V.
dc.contributor.otherHarris, Robert A.
dc.contributor.otherTune, Johnathan David
dc.date.accessioned2016-01-08T16:17:52Z
dc.date.available2016-01-08T16:17:52Z
dc.date.issued2014-10-06
dc.degree.date2015
dc.degree.disciplineDepartment of Cellular & Integrative Physiology
dc.degree.grantorIndiana University
dc.degree.levelPh.D.
dc.descriptionIndiana University-Purdue University Indianapolis (IUPUI)en_US
dc.description.abstractLiterature has demonstrated the ability of human adipose tissue to generate large amounts of lactate. However, it is not understood why adipose tissue produces lactate, how the production of lactate is regulated, and what potential benefit this has to the adipocyte or the organism. We first characterized a human model of adipogenic differentiation with minimal donor to donor variability to assess metabolic changes associated with mature adipocytes compared to their precursors. Indeed, similar to what was observed in human clinical studies, the differentiated adipocytes demonstrated increased lactate production. However, the differentiated adipocytes compared to their precursors (preadipocytes or ASCs) demonstrate an aerobic glycolysis-like (also called Warburg effect-like) increase in glycolysis characterized by a 5.2 fold increase in lactate production in normoxic conditions (atmospheric oxygen tension). Remarkably, this increase in lactate occurred even though the differentiated adipocytes simultaneously demonstrate an increase in oxidative capacity. This low fraction of oxidative capacity coupled with increased lactate production indicated regulation of oxidative rates most likely at the point of pyruvate conversion to either acetyl-CoA (oxidative metabolism) or lactate (glycolytic metabolism). To investigate the potential regulation of this metabolic phenotype, PDK isoform expression was assessed and we found PDK 1 and 4 transcript and protein elevated in the differentiated cells. Non-selective pharmacologic inhibition of the PDKs resulted in decreased lactate production, supporting a regulatory role for PDK in modulation of the observed Warburg effect. PDK inhibition also resulted in increased ROS production in the adipocytes after several hours of treatment and a decrease in cell viability when PDK inhibition was carried out over 36 hours. The resulting loss in viability could be rescued by antioxidant (Tempol) treatment, indicating the decrease in viability was ROS mediated. Similar to what is seen in cancer cells, our data demonstrate that differentiation of human adipocytes is accompanied by a PDK-dependent increase in glycolytic metabolism (Warburg effect) that not only leads to lactate production, but also seems to protect the cells from increased and detrimental generation of ROS.en_US
dc.identifier.urihttps://hdl.handle.net/1805/8009
dc.identifier.urihttp://dx.doi.org/10.7912/C2/2007
dc.language.isoen_USen_US
dc.subjectAdipocyteen_US
dc.subjectAdipogenesisen_US
dc.subjectPDKen_US
dc.subjectROSen_US
dc.subjectWarburgen_US
dc.subject.lcshAdipose tissuesen_US
dc.subject.lcshLactationen_US
dc.subject.lcshGlycolysisen_US
dc.subject.lcshCell respirationen_US
dc.subject.lcshAdipose tissues -- Chemical warfareen_US
dc.subject.lcshGlucose -- Metabolismen_US
dc.subject.lcshCells -- Agingen_US
dc.subject.lcshCells -- Physiologyen_US
dc.titlePDK regulated Warburg effect protects differentiated adipocytes against ROSen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Roell_iupui_0104D_10012.pdf
Size:
18.62 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description: